Patents Assigned to Warner Chilcott Company Inc.
-
Publication number: 20110171299Abstract: The present invention is a solid dosage form of a doxycycline metal complex. The present invention also includes a process for making a doxycycline metal complex in a solid dosage form. The process comprises the steps of (i) providing an aqueous solution of doxycycline or a physiologically acceptable salt thereof; (ii) admixing a metal salt with the aqueous solution; (iii) admixing a base to increase the pH of the aqueous solution, thereby forming a suspension of doxycycline metal; and (iv) drying the suspension, thereby forming a dry granulation of doxycycline metal complex.Type: ApplicationFiled: December 18, 2008Publication date: July 14, 2011Applicant: Warner Chilcott Company, Inc.Inventors: Tina deVries, Lynn Gold
-
Patent number: 7485319Abstract: The present invention is a solid dosage form of a doxycycline metal complex. The present invention also includes a process for making a doxycycline metal complex in a solid dosage form. The process comprises the steps of (i) providing an aqueous solution of doxycycline or a physiologically acceptable salt thereof; (ii) admixing a metal salt with the aqueous solution; (iii) admixing a base to increase the pH of the aqueous solution, thereby forming a suspension of doxycycline metal; and (iv) drying the suspension, thereby forming a dry granulation of doxycycline metal complex.Type: GrantFiled: July 22, 2004Date of Patent: February 3, 2009Assignee: Warner Chilcott Company, Inc.Inventors: Tina deVries, Lynn Gold
-
Publication number: 20080188446Abstract: Pharmaceutical formulations containing tetracycline for topical administration, as well as methods of making and administering the same, are disclosed.Type: ApplicationFiled: February 1, 2008Publication date: August 7, 2008Applicant: WARNER CHILCOTT COMPANY INC.Inventors: Brendan Muldoon, David Woolfson, Stephen McCullagh
-
Publication number: 20080188445Abstract: Multi-part pharmaceutical formulations containing tetracycline for topical administration, as well as methods of making and administering the same, are disclosed.Type: ApplicationFiled: February 1, 2008Publication date: August 7, 2008Applicant: WARNER CHILCOTT COMPANY INC.Inventors: BRENDAN MULDOON, DAVID WOOLFSON, STEPHEN MCCULLAGH
-
Publication number: 20080113953Abstract: Methods of improving the bioavailability of ethinyl estradiol by orally administering to a patient a solid dosage form containing ethinyl estradiol or prodrug thereof where that dosage form releases at least some of the ethinyl estradiol or prodrug thereof in the oral cavity for absorption through the oral mucosa to treat the patient for a predetermined indication such as, for example, hormone replacement therapy or contraception. The solid dosage forms may be selected from, among others, chewable tablets, fast melt tablets, films, dissolving films, mucoadhesive tablets, lozenges, and chewing gum.Type: ApplicationFiled: December 12, 2007Publication date: May 15, 2008Applicant: WARNER CHILCOTT COMPANY, INC.Inventors: Tina De Vries, Brian McNamee
-
Publication number: 20070286819Abstract: Methods of improving the bioavailability of ethinyl estradiol by orally administering to a patient a solid dosage form containing ethinyl estradiol or prodrug thereof where that dosage form releases at least some of the ethinyl estradiol or prodrug thereof in the oral cavity for absorption through the oral mucosa to treat the patient for a predetermined indication such as, for example, hormone replacement therapy or contraception. The solid dosage forms may be selected from, among others, chewable tablets, fast melt tablets, films, dissolving films, mucoadhesive tablets, lozenges, and chewing gum.Type: ApplicationFiled: June 8, 2007Publication date: December 13, 2007Applicant: WARNER CHILCOTT COMPANY, INC.Inventors: Tina DeVries, Brian McNamee
-
Publication number: 20070207945Abstract: A multiphasic method of contraception comprising the steps of sequentially administering to a female of child bearing age a Phase I composition containing a progestogen in an amount equivalent to about 0.3 to about 1.5 mg norethindrone acetate and an estrogen in an amount equivalent to about 5 to about 15 mcg of ethinyl estradiol for about 7 to about 14 days; a Phase II composition containing a progestogen in an amount equivalent to about 0.3 to about 1.5 mg of norethindrone acetate and an estrogen in an amount equivalent to about 10 to about 25 mcg of ethinyl estradiol for about 14 to about 22 days; a Phase III composition containing a progestogen in an amount equivalent to about 0.3 to about 1.Type: ApplicationFiled: February 9, 2007Publication date: September 6, 2007Applicant: Warner Chilcott Company Inc.Inventor: Herman Ellman
-
Publication number: 20070004693Abstract: Pharmaceutical gel compositions containing estrogen for vaginal administration, as well as a method of making the same, are disclosed.Type: ApplicationFiled: June 16, 2006Publication date: January 4, 2007Applicant: WARNER CHILCOTT COMPANY INC.Inventors: David Woolfson, Claire Gilligan
-
Publication number: 20070004694Abstract: Pharmaceutical gel compositions containing estrogen for vaginal administration, as well as a method of making the same, are disclosed.Type: ApplicationFiled: June 16, 2006Publication date: January 4, 2007Applicant: WARNER CHILCOTT COMPANY INC.Inventors: David Woolfson, Karl Malcolm
-
Publication number: 20060292223Abstract: Pharmaceutical gel compositions containing pharmacologically active agent for topical administration, as well as a method of making the same, are disclosed.Type: ApplicationFiled: June 16, 2006Publication date: December 28, 2006Applicant: WARNER CHILCOTT COMPANY INC,Inventors: David Woolfson, Jim Mc Ilroy
-
Patent number: 7067504Abstract: The present invention is a di-steroidal prodrug of ethinyl estradiol according to formula I:Type: GrantFiled: December 10, 2004Date of Patent: June 27, 2006Assignee: Warner Chilcott Company, Inc.Inventors: John Alexander King, James Keown, James William McIlroy, William Paul Armstrong, Michael Anthony McKervey, Austin McMordie
-
Patent number: 7067505Abstract: The present invention is a di-steroidal prodrug of estradiol having the following formula:Type: GrantFiled: December 10, 2004Date of Patent: June 27, 2006Assignee: Warner Chilcott Company, Inc.Inventors: John Alexander King, James Keown, James William McIlroy, William Paul Armstrong, Michael Anthony McKervey, Austin McMordie
-
Patent number: 6962908Abstract: A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17?-estradiol-3-lower alkanoate, most preferably 17?-estradiol-3-acetate, and a pharmaceutically acceptable carrier is disclosed. Also disclosed is a method for treating a human female in need of 17?-estradiol and a contraceptive method by oral administration of the pharmaceutical dosage unit and a method of preparing a pharmaceutical composition that may be used to form the pharmaceutical dosage unit of the invention.Type: GrantFiled: December 21, 2001Date of Patent: November 8, 2005Assignee: Warner Chilcott Company Inc.Inventors: Oluwole T. Aloba, Tina M. deVries
-
Publication number: 20050234028Abstract: A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17?-estradiol-3-lower alkanoate, most preferably 17?-estradiol-3-acetate, and a pharmaceutically acceptable carrier is disclosed. Also disclosed is a method for treating a human female in need of 17?-estradiol and a contraceptive method by oral administration of the pharmaceutical dosage unit and a method of preparing a pharmaceutical composition that may be used to form the pharmaceutical dosage unit of the invention.Type: ApplicationFiled: June 17, 2005Publication date: October 20, 2005Applicant: Warner Chilcott Company Inc.Inventors: Oluwole Aloba, Tina deVries